Literature DB >> 29413653

Lobular Carcinoma In Situ.

Hannah Y Wen1, Edi Brogi2.   

Abstract

Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is approximately 9 to 10 times that of the general population. Classic LCIS diagnosed on core biopsy with concordant imaging and pathologic findings does not mandate surgical excision, and margin status is not reported. The identification of variant LCIS in a needle core biopsy specimen mandates surgical excision, regardless of radiologic-pathologic concordance. The presence of variant LCIS close to the surgical margin of a resection specimen is reported, and reexcision should be considered.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CDH1; Core biopsy; E-cadherin; Pleomorphic lobular carcinoma in situ; Variant lobular carcinoma in situ; p120

Mesh:

Year:  2017        PMID: 29413653      PMCID: PMC5841603          DOI: 10.1016/j.path.2017.09.009

Source DB:  PubMed          Journal:  Surg Pathol Clin        ISSN: 1875-9157


  136 in total

1.  Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.

Authors:  Samantha Hansford; Pardeep Kaurah; Hector Li-Chang; Michelle Woo; Janine Senz; Hugo Pinheiro; Kasmintan A Schrader; David F Schaeffer; Karey Shumansky; George Zogopoulos; Teresa Almeida Santos; Isabel Claro; Joana Carvalho; Cydney Nielsen; Sarah Padilla; Amy Lum; Aline Talhouk; Katie Baker-Lange; Sue Richardson; Ivy Lewis; Noralane M Lindor; Erin Pennell; Andree MacMillan; Bridget Fernandez; Gisella Keller; Henry Lynch; Sohrab P Shah; Parry Guilford; Steven Gallinger; Giovanni Corso; Franco Roviello; Carlos Caldas; Carla Oliveira; Paul D P Pharoah; David G Huntsman
Journal:  JAMA Oncol       Date:  2015-04       Impact factor: 31.777

2.  Collagenous spherulosis of the breast.

Authors:  P B Clement; R H Young; J G Azzopardi
Journal:  Am J Surg Pathol       Date:  1987-06       Impact factor: 6.394

3.  Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.

Authors:  Tari A King; Melissa Pilewskie; Shirin Muhsen; Sujata Patil; Starr K Mautner; Anna Park; Sabine Oskar; Elena Guerini-Rocco; Camilla Boafo; Jessica C Gooch; Marina De Brot; Jorge S Reis-Filho; Mary Morrogh; Victor P Andrade; Rita A Sakr; Monica Morrow
Journal:  J Clin Oncol       Date:  2015-09-14       Impact factor: 44.544

4.  Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings.

Authors:  L Liberman; M Sama; B Susnik; P P Rosen; L R LaTrenta; E A Morris; A F Abramson; D D Dershaw
Journal:  AJR Am J Roentgenol       Date:  1999-08       Impact factor: 3.959

5.  E-cadherin germline mutations in familial gastric cancer.

Authors:  P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

6.  Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?

Authors:  Lavinia P Middleton; Shakeitha Grant; Tanya Stephens; Carol B Stelling; Nour Sneige; Aysegul A Sahin
Journal:  Mod Pathol       Date:  2003-02       Impact factor: 7.842

7.  Lobular neoplasia on core needle biopsy does not require excision.

Authors:  Chandandeep S Nagi; James E O'Donnell; Mikhail Tismenetsky; Ira J Bleiweiss; Shabnam M Jaffer
Journal:  Cancer       Date:  2008-05-15       Impact factor: 6.860

8.  Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.

Authors:  R Moll; M Mitze; U H Frixen; W Birchmeier
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

9.  Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020).

Authors:  Faina Nakhlis; Lauren Gilmore; Rebecca Gelman; Isabelle Bedrosian; Kandice Ludwig; E Shelley Hwang; Shawna Willey; Clifford Hudis; J Dirk Iglehart; Elizabeth Lawler; Nicole Y Ryabin; Mehra Golshan; Stuart J Schnitt; Tari A King
Journal:  Ann Surg Oncol       Date:  2015-11-05       Impact factor: 5.344

10.  Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family.

Authors:  Tarek M A Abdel-Fatah; Desmond G Powe; Zsolt Hodi; Jorge S Reis-Filho; Andrew H S Lee; Ian O Ellis
Journal:  Am J Surg Pathol       Date:  2008-04       Impact factor: 6.394

View more
  14 in total

1.  Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations.

Authors:  Beth T Harrison; Faina Nakhlis; Deborah A Dillon; T Rinda Soong; Elizabeth P Garcia; Stuart J Schnitt; Tari A King
Journal:  Mod Pathol       Date:  2020-01-13       Impact factor: 7.842

Review 2.  Inflammation, immunosuppressive microenvironment and breast cancer: opportunities for cancer prevention and therapy.

Authors:  Sachin Kumar Deshmukh; Sanjeev Kumar Srivastava; Teja Poosarla; Donna Lynn Dyess; Nicolette Paolaungthong Holliday; Ajay Pratap Singh; Seema Singh
Journal:  Ann Transl Med       Date:  2019-10

Review 3.  American Registry of Pathology Expert Opinions: The Spectrum of Lobular Carcinoma in Situ: Diagnostic Features and Clinical Implications.

Authors:  Stuart J Schnitt; Edi Brogi; Yunn-Yi Chen; Tari A King; Sunil R Lakhani
Journal:  Ann Diagn Pathol       Date:  2020-02-15       Impact factor: 2.090

4.  Synchronous and metachronous bilateral breast cancer among women with a history of lobular carcinoma in situ.

Authors:  Melissa Anne Mallory; Karissa Whiting; Anna Park; Mithat Gönen; Elizabeth Gilbert; Tari A King; Melissa L Pilewskie
Journal:  Breast Cancer Res Treat       Date:  2022-04-29       Impact factor: 4.872

5.  Metaplastic Matrix-Producing Carcinoma and Apocrine Lobular Carcinoma In Situ Associated with Microglandular Adenosis: A Unique Case Report.

Authors:  Nektarios Koufopoulos; Dionysios Dimas; Foteini Antoniadou; Kyparissia Sitara; Dimitrios Balalis; Ioannis Boutas; Alina Roxana Gouloumis; Adamantia Kontogeorgi; Lubna Khaldi
Journal:  Diagnostics (Basel)       Date:  2022-06-13

6.  Identification of a 5-gene-risk score model for predicting luminal A-invasive lobular breast cancer survival.

Authors:  Yi-Huan Chen; Tao-Feng Zhang; Yi-Yuan Liu; Jie-Hua Zheng; Wei-Xun Lin; Yao-Kun Chen; Jie-Hui Cai; Juan Zou; Zhi-Yang Li
Journal:  Genetica       Date:  2022-05-10       Impact factor: 1.633

7.  Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision.

Authors:  M Gabriela Kuba; Melissa P Murray; Kristen Coffey; Catarina Calle; Monica Morrow; Edi Brogi
Journal:  Mod Pathol       Date:  2021-04-06       Impact factor: 7.842

8.  Silencing of Nek2 suppresses the proliferation, migration and invasion and induces apoptosis of breast cancer cells by regulating ERK/MAPK signaling.

Authors:  Zeyu Xing; Menglu Zhang; Xin Wang; Jiaqi Liu; Gang Liu; Kexin Feng; Xiang Wang
Journal:  J Mol Histol       Date:  2021-05-19       Impact factor: 2.611

9.  Inter-observer reproducibility of classical lobular neoplasia (B3 lesions) in preoperative breast biopsies: a study of the Swiss Working Group of breast and gynecopathologists.

Authors:  Linda Moskovszky; Barbara Berger; Achim Fleischmann; Thomas Friedrich; Birgit Helmchen; Meike Körner; Tilman T Rau; Zsuzsanna Varga
Journal:  J Cancer Res Clin Oncol       Date:  2020-03-30       Impact factor: 4.553

10.  A bioinformatics approach to identify novel long, non-coding RNAs in breast cancer cell lines from an existing RNA-sequencing dataset.

Authors:  Oza Zaheed; Julia Samson; Kellie Dean
Journal:  Noncoding RNA Res       Date:  2020-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.